Thu, Aug 21, 2014, 9:46 AM EDT - U.S. Markets close in 6 hrs 14 mins


% | $
Quotes you view appear here for quick access.

ViroPharma Incorporated Message Board

  • campusjuarez campusjuarez Jan 5, 2009 12:17 PM Flag

    Back to twenties?

    Is there some logic or base for you investor to think that VPHM will go back to previous price levels? I mean, in low twenties as it was in early 2006, before all the mess we know?
    I really appreciate any serious comment that you might have in positive or negative direction.
    At this moment in my case I am skeptical I do not believe in this company but maybe I am completely wrong.
    Thanks in advance,

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • mid-20's in early 2006 is correct before AKRX and the FDA and the OGD and whoever else tried to break all the rules and get possibly untested and bad drugs into hospitals. Thankfully, VPHM has been able to thwart this disgrace and has maintained their market dominance AND SAVED PATIENT'S LIVES! That's what health care is supposed to be all about. In the mean time they cobbled together a brilliant deal with Lev. Beyond that, in their spare time they have maribavir at the doorstep of approval. A $20 stock? How about a $40 stock. This company has beat revenue forcasts over and over again. They have been profitable quarter after quarter. Wall Street puts higher valuations on research biotech companies that loss millions every quarter than on a solid well run company. See how well Wall Street's valuation models played out the last two years?

    • A few of us think it should have been there all along!

49.96-0.01(-0.02%)Jan 23 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.